4 May, 2018

Circulogene’s PD-L1 Expression Test Featured in Clinical Lab Products Magazine

In the latest feature from Clinical Lab Products magazine, experts from First Health, Banner Health and Biodesix Inc. discuss progress and challenges on the way to a blood-based assay for PD-L1. The article, "Overcoming Immune Blockade in [...]

3 May, 2018

The Evolution of In Situ Genetic Technology

This review presents a perspective of in situ genetic technology, including a summary of the methods, principles, endpoints, and applications. The class of in situ genetic techniques has been used for direct measurement of gene functions in specific cell [...]

6 Feb, 2018

Somatic Mutations in Cancer-Free Individuals: A Liquid Biopsy Connection

Somatic Mutations in Cancer-Free Individuals: A Liquid Biopsy Connection Open Acc J Oncol Med 2018. Abstract  Somatic mutations have been perceived as the causal event in the origin of the vast majority of cancers. Advanced massively [...]

12 Jan, 2018

Pre-Analytical Assessment of Circulating Cell-Free DNA Prepared by An Isolation-Free Enrichment Technology

Publication: ACTA Scientific Cancer Biology Volume 2 Issue 1 January 2018 Abstract Quantity and quality of circulating cell-free DNA (cfDNA) from plasma is highly variable, with frequent contamination of larger, genomic DNA as a consequence [...]

11 Jan, 2018

2018 Research Confirms Circulogene’s Clean Technology

Circulogene's Chief Scientific Officer, Dr. Chen-Hsiung Yeh, authored the latest research findings in ACTA Scientific Cancer Biology, Volume 2, Issue 1. This is the first paper released in 2018, which has important findings that include: Confirming, [...]

3 Jan, 2018

CIRCULOGENE Announces International Licensing of Proprietary Molecular Diagnostics Testing Technology to Turkey-Based Laboratory

CIRCULOGENE Announces International Licensing of Proprietary Molecular Diagnostics Testing Technology to Turkey-Based Laboratory Company expands single-blood-tube, cancer-targeted therapy and immunotherapy testing to parts of Europe, Africa, the Middle East and Commonwealth of Independent States (CIS) [...]

29 Nov, 2017

CIRCULOGENE Appoints Dr. Glen J. Weiss as Chief Medical Officer

BIRMINGHAM, Ala. ­­­– CIRCULOGENE, advancing precision medicine through personalized molecular genetics testing, has named medical oncologist and cancer researcher Glen J. Weiss, M.D., MBA, as Chief Medical Officer. Dr. Weiss will oversee and advance the [...]

17 Nov, 2017

Circulogene Featured in Genetic Engineering & Biotechnology News

November 15, 2017 Circulogene's Chen-Hsiung Yeh, Ph.D., CSO, was recently featured in a new article titled, Cell-Free DNA Drives Liquid Biopsy Testing published by Genetic Engineering & Biotechnology News. "Chen-Hsiung Yeh, Ph.D., CSO, Circulogene Theranostics, believes that what makes [...]

15 Nov, 2017

CIRCULOGENE Introduces Single-Tube, Blood-Based Microsatellite Instability (MSI) Biomarker Testing for Multiple Cancers

MSI Diagnostic Testing Available for Precision Cancer Immunotherapy BIRMINGHAM, Ala.--(BUSINESS WIRE)-- CIRCULOGENE, a leading liquid biopsy company advancing precision medicine through personalized molecular genetics testing, has announced the availability of microsatellite instability (MSI) biomarker testing for [...]

31 Oct, 2017

Key Player for Global Liquid Biopsy market

Market Research Future published a research report on "Global Liquid Biopsy Market Research Report- Forecast to 2022" and named Circulogene as one of the top key players for the global liquid biopsy market. Read more: http://www.digitaljournal.com/pr/3540438#ixzz4x60f7KoO [...]